• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Warby Parker Announces Third Quarter 2025 Results

    11/6/25 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care
    Get the next $WRBY alert in real time by email

    Net revenue growth accelerated to 15% year over year

    Active Customers growth accelerated to 9% on a trailing 12-month basis

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the third quarter ended September 30, 2025.

    "This was a strong quarter for our team as we advanced our strategic priorities and accelerated both topline and customer growth. As we step into Warby Parker's next act, one defined by innovation through AI, we're energized to create new products like AI glasses, enhance the customer experience and drive productivity," shared Co-Founder and Co-CEO Neil Blumenthal.

    "We meaningfully expanded profitability this quarter, reflecting the strength of our operational discipline and focus on sustainable growth. We believe our differentiated value proposition continues to resonate with customers and we are well-positioned to take share in any environment," added Co-Founder and Co-CEO Dave Gilboa.

    Third Quarter 2025 Highlights

    • Net revenue increased $29.2 million, or 15.2%, to $221.7 million, as compared to the prior year period.
    • Active Customers increased 9.3% to 2.66 million on a trailing 12-month basis and Average Revenue per Customer increased 4.8% year over year to $320.
    • Net income improved $9.9 million to $5.9 million, as compared to the prior year period.
    • Adjusted EBITDA(1) increased $8.4 million year over year to $25.7 million and Adjusted EBITDA Margin(1) increased 2.6 points to 11.6%.
    • Opened 15 net new stores during the quarter, ending Q3 with 313 stores.

    Third Quarter 2025 Year Over Year Financial Results

    • Net revenue increased $29.2 million, or 15.2%, to $221.7 million.
    • Active Customers increased 9.3% to 2.66 million on a trailing 12-month basis and Average Revenue per Customer increased 4.8% to $320.
    • Gross margin was 54.1% compared to 54.5% in the prior year. The decrease in gross margin was primarily driven by the impact of tariffs on glasses, sales growth of contact lenses, and increased customer shipping costs, partially offset by the benefit from selective price increases in glasses in the second quarter and increased penetration of precision progressives and other lens enhancements. Adjusted Gross Margin(1) was 54.2%, compared to 54.6% in the prior year.
    • Selling, general, and administrative expenses ("SG&A") were $116.4 million, up $4.9 million from the prior year, and represented 52.5% of revenue, down from 57.9% in the prior year. As a percentage of revenue, SG&A decreased primarily due to leverage from corporate expenses and our customer experience team, as well as lower stock-based compensation, partially offset by growth in marketing. Adjusted SG&A(1) was $108.0 million, or 48.7% of revenue, compared to $100.6 million, or 52.3% of revenue, in the prior year.
    • Net income improved $9.9 million to $5.9 million primarily as a result of leveraging our expense base on higher revenue.
    • Adjusted EBITDA(1) increased $8.4 million to $25.7 million and Adjusted EBITDA Margin(1) increased 2.6 points to 11.6%.

    Balance Sheet and Cash Flow Highlights

    • Ended the third quarter of 2025 with $280.4 million in cash and cash equivalents.
    • Year to date net cash provided by operating activities of $87.5 million and Free Cash Flow(1) of $35.6 million.

    2025 Outlook

    For the full year 2025, Warby Parker is updating its guidance as follows:

    • Net revenue of $871 million to $874 million, representing growth of approximately 13%.
    • Adjusted EBITDA(1) of $98 million to $101 million, representing an Adjusted EBITDA Margin(1) of 11.3% to 11.6%, and 180 to 210 basis points of year over year expansion.
    • On track to open 45 new stores, including five previously opened shop-in-shops at select Target locations.

    The guidance and forward-looking statements made in this press release and on our conference call are based on management's expectations as of the date of this press release.

    (1) Please see the reconciliation of non-GAAP financial measures to the most comparable GAAP financial measure in the section titled "Non-GAAP Financial Measures" below.

    Webcast and Conference Call

    A conference call to discuss Warby Parker's third quarter 2025 results, as well as fourth quarter and full year 2025 outlook, is scheduled for 8:00 a.m. ET on November 6, 2025. To participate, please dial 833-470-1428 from the U.S. or 646-844-6383 from international locations. The conference passcode is 958403. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where presentation materials will also be posted prior to the conference call. A replay will be made available online approximately two hours following the live call for a period of 90 days.

    Forward-Looking Statements

    This press release and the related conference call, webcast and presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, expectations of future operating results or financial performance; expectations regarding the growth of our business, delivering stakeholder value and growing market share; expectations regarding the development of new products; our guidance for the year ending December 31, 2025; expectations regarding the number of new store openings during the year ending December 31, 2025; and management's plans, priorities, initiatives and strategies. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "toward," "will," or "would," or the negative of these words or other similar terms or expressions. You should not put undue reliance on any forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved, if at all.

    Forward-looking statements are based on information available at the time those statements are made and are based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control, that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. These risks and uncertainties include our ability to manage our future growth effectively; our expectations regarding cost of goods sold, gross margin, channel mix, customer mix, and selling, general, and administrative expenses; increases in component and shipping costs and changes in supply chain; changes to U.S. or other countries' trade policies and tariff and import/export regulations; our reliance on our information technology systems and enterprise resource planning systems for our business to effectively operate and safeguard confidential information; our ability to invest in and incorporate new technologies into our products and services; risks related to our use of artificial intelligence; our ability to engage our existing customers and obtain new customers; our ability to expand in-network access with insurance providers; planned new retail stores in 2025 and going forward; an overall decline in the health of the economy and other factors impacting consumer spending, such as recessionary conditions, inflation, infectious diseases, government instability, and geopolitical unrest; our ability to compete successfully; our ability to manage our inventory balances and shrinkage; the growth of our brand awareness; our ability to recruit and retain optometrists, opticians, and other vision care professionals; the effects of seasonal trends on our results of operations; our ability to stay in compliance with extensive laws and regulations that apply to our business and operations; our ability to adequately maintain and protect our intellectual property and proprietary rights; our reliance on third parties for our products, operation and infrastructure; our duties related to being a public benefit corporation; the ability of our Co-Founders and Co-CEOs to exercise significant influence over all matters submitted to stockholders for approval; the effect of our multi-class structure on the trading price of our Class A common stock; our ability to achieve milestones necessary for Google's equity investment into the Company and Google's contribution to product development and commercialization costs; our ability to collaborate with partners with successful results; our ability to recognize the anticipated benefits from partnerships, including with Google and Samsung; and the increased expenses associated with being a public company. Additional information regarding these and other risks and uncertainties that could cause actual results to differ materially from the Company's expectations is included in our most recent reports filed with the SEC on Form 10-K and Form 10-Q. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

    Additional information regarding these and other factors that could affect the Company's results is included in the Company's SEC filings, which may be obtained by visiting the SEC's website at www.sec.gov. Information contained on, or that is referenced or can be accessed through, our website does not constitute part of this document and inclusions of any website addresses herein are inactive textual references only.

    Glossary

    Active Customers is defined as unique customer accounts that have made at least one purchase in the preceding 12-month period.

    Average Revenue per Customer is defined as the sum of the total net revenues in the preceding 12-month period divided by the current period Active Customers.

    Non-GAAP Financial Measures

    We use Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Cost of Goods Sold ("Adjusted COGS"), Adjusted Gross Margin, Adjusted Gross Profit, Adjusted Selling, General, and Administrative Expenses ("Adjusted SG&A"), and Free Cash Flow as important indicators of our operating performance. Collectively, we refer to these non-GAAP financial measures as our "Non-GAAP Measures." The Non-GAAP Measures, when taken collectively with our GAAP results, may be helpful to investors because they provide consistency and comparability with past financial performance and assist in comparisons with other companies, some of which use similar non-GAAP financial information to supplement their GAAP results.

    Adjusted EBITDA is defined as net income before interest and other income, taxes, and depreciation and amortization as further adjusted for asset impairment costs, stock-based compensation expense and related employer payroll taxes, amortization of cloud-based software implementation costs, non-cash charitable donations, charges for certain legal matters outside the ordinary course of business, and non-recurring costs such as restructuring costs and major system implementation costs. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by net revenue.

    Adjusted COGS is defined as cost of goods sold adjusted for stock-based compensation expense and related employer payroll taxes and non-recurring costs.

    Adjusted Gross Profit is defined as net revenue minus Adjusted COGS. Adjusted Gross Margin is defined as Adjusted Gross Profit divided by net revenue.

    Adjusted SG&A is defined as SG&A adjusted for stock-based compensation expense and related employer payroll taxes, non-cash charitable donations, charges for certain legal matters outside the ordinary course of business, and non-recurring costs such as restructuring costs and major system implementation costs.

    Free Cash Flow is defined as net cash provided by operating activities minus purchases of property and equipment.

    The Non-GAAP Measures are presented for supplemental informational purposes only. A reconciliation of historical GAAP to Non-GAAP financial information is included under "Selected Financial Information" below.

    We have not reconciled our Adjusted EBITDA Margin guidance to GAAP net income margin, or net margin, or Adjusted EBITDA guidance to GAAP net income because we do not provide guidance for GAAP net margin or GAAP net income due to the uncertainty and potential variability of stock-based compensation and taxes, which are reconciling items between GAAP net margin and Adjusted EBITDA Margin and GAAP net income and Adjusted EBITDA, respectively. Because such items cannot be reasonably provided without unreasonable efforts, we are unable to provide a reconciliation of the Adjusted EBITDA Margin guidance to GAAP net margin and Adjusted EBITDA guidance to GAAP net income. However, such items could have a significant impact on GAAP net margin and GAAP net income.

    About Warby Parker

    Warby Parker (NYSE:WRBY) was founded in 2010 with a mission to inspire and impact the world with vision, purpose, and style–without charging a premium for it. Headquartered in New York City, the co-founder-led lifestyle brand pioneers ideas, designs products, and develops technologies that help people see, from designer-quality prescription glasses (starting at $95) and contacts, to eye exams and vision tests available online and in our 313 retail stores across the U.S. and Canada.

    Warby Parker aims to demonstrate that businesses can scale, do well, and do good in the world. Ultimately, the Company believes in vision for all, which is why for every pair of glasses or sunglasses sold, it distributes a pair to someone in need through its Buy a Pair, Give a Pair program. To date, Warby Parker has worked alongside its nonprofit partners to distribute more than 20 million glasses to people in need.

    Selected Financial Information

    Warby Parker Inc. and Subsidiaries

    Condensed Consolidated Balance Sheets (Unaudited)

    (Amounts in thousands, except par value)

     

    September 30,

    2025

     

    December 31,

    2024

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    280,360

     

     

    $

    254,161

     

    Accounts receivable, net

     

    1,143

     

     

     

    1,948

     

    Inventory

     

    45,592

     

     

     

    52,345

     

    Prepaid expenses and other current assets

     

    16,962

     

     

     

    17,592

     

    Total current assets

     

    344,057

     

     

     

    326,046

     

     

     

     

     

    Property and equipment, net

     

    182,576

     

     

     

    170,464

     

    Right-of-use lease assets

     

    171,508

     

     

     

    171,284

     

    Other assets

     

    8,780

     

     

     

    8,696

     

    Total assets

    $

    706,921

     

     

    $

    676,490

     

     

     

     

     

    Liabilities and stockholders' equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    10,886

     

     

    $

    23,519

     

    Accrued expenses

     

    67,641

     

     

     

    51,609

     

    Deferred revenue

     

    21,997

     

     

     

    32,358

     

    Current lease liabilities

     

    28,641

     

     

     

    20,235

     

    Other current liabilities

     

    2,900

     

     

     

    2,633

     

    Total current liabilities

     

    132,065

     

     

     

    130,354

     

     

     

     

     

    Non-current lease liabilities

     

    203,885

     

     

     

    205,120

     

    Other liabilities

     

    1,346

     

     

     

    943

     

    Total liabilities

     

    337,296

     

     

     

    336,417

     

    Commitments and contingencies

     

     

     

    Stockholders' equity:

     

     

     

    Common stock, $0.0001 par value; Class A: 750,000 shares authorized at September 30, 2025 and December 31, 2024, 105,602 and 102,889 issued and outstanding at September 30, 2025 and December 31, 2024, respectively; Class B: 150,000 shares authorized at September 30, 2025 and December 31, 2024, 16,563 and 17,961 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively, convertible to Class A on a one-to-one basis

     

    12

     

     

     

    12

     

    Additional paid-in capital

     

    1,050,899

     

     

     

    1,029,220

     

    Accumulated deficit

     

    (679,627

    )

     

     

    (687,221

    )

    Accumulated other comprehensive loss

     

    (1,659

    )

     

     

    (1,938

    )

    Total stockholders' equity

     

    369,625

     

     

     

    340,073

     

    Total liabilities and stockholders' equity

    $

    706,921

     

     

    $

    676,490

     

     

    Warby Parker Inc. and Subsidiaries

    Condensed Consolidated Statements of Operations (Unaudited)

    (Amounts in thousands, except per share data)

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

     

    2025

     

    2024

     

    2025

     

    2024

    Net revenue

    $

    221,680

     

     

    $

    192,447

     

     

    $

    659,937

     

    $

    580,672

     

    Cost of goods sold

     

    101,735

     

     

     

    87,580

     

     

     

    300,401

     

     

    256,964

     

    Gross profit

     

    119,945

     

     

     

    104,867

     

     

     

    359,536

     

     

    323,708

     

     

     

     

     

     

     

     

     

    Selling, general, and administrative expenses

     

    116,375

     

     

     

    111,480

     

     

     

    358,020

     

     

    344,404

     

    Income (loss) from operations

     

    3,570

     

     

     

    (6,613

    )

     

     

    1,516

     

     

    (20,696

    )

     

     

     

     

     

     

     

     

    Interest and other income, net

     

    2,179

     

     

     

    2,842

     

     

     

    6,618

     

     

    7,965

     

     

     

     

     

     

     

     

     

    Income (loss) before income taxes

     

    5,749

     

     

     

    (3,771

    )

     

     

    8,134

     

     

    (12,731

    )

    (Benefit from) provision for income taxes

     

    (125

    )

     

     

    301

     

     

     

    540

     

     

    782

     

    Net income (loss)

    $

    5,874

     

     

    $

    (4,072

    )

     

    $

    7,594

     

    $

    (13,513

    )

     

     

     

     

     

     

     

     

    Earnings (loss) per share:

     

     

     

     

     

     

     

    Basic

    $

    0.05

     

     

    $

    (0.03

    )

     

    $

    0.06

     

    $

    (0.11

    )

    Diluted

    $

    0.05

     

     

    $

    (0.03

    )

     

    $

    0.06

     

    $

    (0.11

    )

     

     

     

     

     

     

     

     

    Weighted average shares outstanding:

     

     

     

     

     

     

     

    Basic

     

    122,963

     

     

     

    120,886

     

     

     

    122,495

     

     

    120,042

     

    Diluted

     

    125,408

     

     

     

    120,886

     

     

     

    124,893

     

     

    120,042

     

     

    Warby Parker Inc. and Subsidiaries

    Condensed Consolidated Statements of Cash Flows (Unaudited)

    (Amounts in thousands)

     

    Nine Months Ended September 30,

     

    2025

     

    2024

    Cash flows from operating activities

     

     

     

    Net income (loss)

    $

    7,594

     

     

    $

    (13,513

    )

    Adjustments to reconcile net income (loss) to net cash provided by operating activities:

     

     

     

    Depreciation and amortization

     

    37,179

     

     

     

    33,533

     

    Stock-based compensation

     

    28,260

     

     

     

    38,664

     

    Non-cash charitable contribution

     

    2,821

     

     

     

    2,196

     

    Asset impairment charges

     

    511

     

     

     

    522

     

    Amortization of cloud-based software implementation costs

     

    2,391

     

     

     

    2,862

     

    Change in operating assets and liabilities:

     

     

     

    Accounts receivable, net

     

    805

     

     

     

    686

     

    Inventory

     

    6,753

     

     

     

    9,468

     

    Prepaid expenses and other assets

     

    (1,847

    )

     

     

    (1,148

    )

    Accounts payable

     

    (11,103

    )

     

     

    13,267

     

    Accrued expenses

     

    17,132

     

     

     

    2,728

     

    Deferred revenue

     

    (10,361

    )

     

     

    (12,401

    )

    Lease assets and liabilities

     

    6,947

     

     

     

    2,469

     

    Other liabilities

     

    449

     

     

     

    (501

    )

    Net cash provided by operating activities

     

    87,531

     

     

     

    78,832

     

    Cash flows from investing activities

     

     

     

    Purchases of property and equipment

     

    (51,928

    )

     

     

    (46,311

    )

    Investment in optical equipment company

     

    —

     

     

     

    (2,000

    )

    Net cash used in investing activities

     

    (51,928

    )

     

     

    (48,311

    )

    Cash flows from financing activities

     

     

     

    Proceeds from stock option exercises

     

    149

     

     

     

    2,686

     

    Shares withheld for taxes on stock-based compensation

     

    (11,001

    )

     

     

    —

     

    Proceeds from shares issued in connection with employee stock purchase plan

     

    1,169

     

     

     

    1,068

     

    Net cash (used in) provided by financing activities

     

    (9,683

    )

     

     

    3,754

     

    Effect of exchange rates on cash

     

    279

     

     

     

    (137

    )

    Net change in cash and cash equivalents

     

    26,199

     

     

     

    34,138

     

    Cash and cash equivalents, beginning of period

     

    254,161

     

     

     

    216,894

     

    Cash and cash equivalents, end of period

    $

    280,360

     

     

    $

    251,032

     

    Supplemental disclosures

     

     

     

    Cash paid for income taxes

    $

    708

     

     

    $

    782

     

    Cash paid for interest

     

    249

     

     

     

    169

     

    Non-cash investing and financing activities:

     

     

     

    Purchases of property and equipment included in accounts payable and accrued expenses

    $

    2,292

     

     

    $

    5,553

     

     

    Warby Parker Inc. and Subsidiaries

    Reconciliation of GAAP to Non-GAAP Measures (Unaudited)

    The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to the most directly comparable GAAP measure, which is net income:

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

     

    2025

     

    2024

     

    2025

     

    2024

     

    (unaudited, in thousands)

     

    (unaudited, in thousands)

    Net income (loss)

    $

    5,874

     

     

    $

    (4,072

    )

     

    $

    7,594

     

     

    $

    (13,513

    )

    Adjusted to exclude the following:

     

     

     

     

     

     

     

    Interest and other income, net

     

    (2,179

    )

     

     

    (2,842

    )

     

     

    (6,618

    )

     

     

    (7,965

    )

    (Benefit from) provision for income taxes

     

    (125

    )

     

     

    301

     

     

     

    540

     

     

     

    782

     

    Depreciation and amortization expense

     

    12,532

     

     

     

    11,829

     

     

     

    37,179

     

     

     

    33,533

     

    Asset impairment charges

     

    25

     

     

     

    101

     

     

     

    511

     

     

     

    522

     

    Stock-based compensation expense(1)

     

    7,328

     

     

     

    10,961

     

     

     

    29,490

     

     

     

    39,373

     

    Non-cash charitable donation(2)

     

    —

     

     

     

    —

     

     

     

    2,821

     

     

     

    2,196

     

    Amortization of cloud-based software implementation costs

     

    903

     

     

     

    854

     

     

     

    2,391

     

     

     

    2,862

     

    System implementation costs(3)

     

    827

     

     

     

    —

     

     

     

    1,173

     

     

     

    —

     

    Inventory write-downs(4)

     

    —

     

     

     

    —

     

     

     

    2,456

     

     

     

    —

     

    Other costs(5)

     

    560

     

     

     

    176

     

     

     

    2,428

     

     

     

    1,479

     

    Adjusted EBITDA

    $

    25,745

     

     

    $

    17,308

     

     

    $

    79,965

     

     

    $

    59,269

     

    Adjusted EBITDA Margin

     

    11.6

    %

     

     

    9.0

    %

     

     

    12.1

    %

     

     

    10.2

    %

    (1)

    Represents expenses related to the Company's equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions. For the three months ended September 30, 2025 and 2024, the amount includes $0.3 million and $0.2 million, respectively, of employer payroll taxes associated with releases of RSUs and option exercises. For the nine months ended September 30, 2025 and 2024, the amount includes $1.2 million and $0.7 million, respectively, of employer payroll taxes associated with releases of RSUs and option exercises.

    (2)

    Represents charitable expense recorded in connection with the donation of 178,572 shares of Class A common stock in both May 2025 and May 2024 to the Warby Parker Impact Foundation.

    (3)

    Represents costs related to the implementation of major new enterprise software systems.

    (4)

    Represents one-time inventory write-downs primarily related to the decision to sunset our Home-Try On program at the end of this year.

    (5)

    Represents restructuring costs incurred in the second quarter of 2025 and charges for certain legal matters outside the ordinary course of business.

     

    Warby Parker Inc. and Subsidiaries

    Reconciliation of GAAP to Non-GAAP Measures (Unaudited)

    The following table presents our non-GAAP, or adjusted, financial measures for the periods presented as a percentage of revenue. Each cost and operating expense is adjusted for stock-based compensation expense and related employer payroll taxes, non-cash charitable donations, charges for certain legal matters outside the ordinary course of business, and non-recurring costs such as restructuring costs and major system implementation costs.

     

    Reported

     

    Adjusted

     

    Reported

     

    Adjusted

     

    Three Months Ended

    September 30,

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     

    (unaudited, in thousands)

     

    (unaudited, in thousands)

     

    (unaudited, in thousands)

     

    (unaudited, in thousands)

    Cost of goods sold

    $

    101,735

     

     

    $

    87,580

     

     

    $

    101,436

     

     

    $

    87,299

     

     

    $

    300,401

     

     

    $

    256,964

     

     

    $

    297,063

     

     

    $

    256,154

     

    % of Revenue

     

    45.9

    %

     

     

    45.5

    %

     

     

    45.8

    %

     

     

    45.4

    %

     

     

    45.5

    %

     

     

    44.3

    %

     

     

    45.0

    %

     

     

    44.1

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Gross profit

    $

    119,945

     

     

    $

    104,867

     

     

    $

    120,244

     

     

    $

    105,148

     

     

    $

    359,536

     

     

    $

    323,708

     

     

    $

    362,874

     

     

    $

    324,518

     

    % of Revenue

     

    54.1

    %

     

     

    54.5

    %

     

     

    54.2

    %

     

     

    54.6

    %

     

     

    54.5

    %

     

     

    55.7

    %

     

     

    55.0

    %

     

     

    55.9

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Selling, general, and administrative expenses

    $

    116,375

     

     

    $

    111,480

     

     

    $

    107,959

     

     

    $

    100,624

     

     

    $

    358,020

     

     

    $

    344,404

     

     

    $

    322,990

     

     

    $

    302,166

     

    % of Revenue

     

    52.5

    %

     

     

    57.9

    %

     

     

    48.7

    %

     

     

    52.3

    %

     

     

    54.2

    %

     

     

    59.3

    %

     

     

    48.9

    %

     

     

    52.0

    %

     

    Warby Parker Inc. and Subsidiaries

    Reconciliation of GAAP to Non-GAAP Measures (Unaudited)

    The following table reflects a reconciliation of each non-GAAP, or adjusted, financial measure to its most directly comparable financial measure prepared in accordance with GAAP:

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

     

    2025

     

    2024

     

    2025

     

    2024

     

    (unaudited, in thousands)

     

    (unaudited, in thousands)

    Cost of goods sold

    $

    101,735

     

     

    $

    87,580

     

     

    $

    300,401

     

     

    $

    256,964

     

    Adjusted to exclude the following:

     

     

     

     

     

     

     

    Stock-based compensation expense(1)

     

    299

     

     

     

    281

     

     

     

    882

     

     

     

    810

     

    Inventory write-downs(2)

     

    —

     

     

     

    —

     

     

     

    2,456

     

     

     

    —

     

    Adjusted Cost of Goods Sold

    $

    101,436

     

     

    $

    87,299

     

     

    $

    297,063

     

     

    $

    256,154

     

     

     

     

     

     

     

     

     

    Gross profit

    $

    119,945

     

     

    $

    104,867

     

     

    $

    359,536

     

     

    $

    323,708

     

    Adjusted to exclude the following:

     

     

     

     

     

     

     

    Stock-based compensation expense(1)

     

    299

     

     

     

    281

     

     

     

    882

     

     

     

    810

     

    Inventory write-downs(2)

     

    —

     

     

     

    —

     

     

     

    2,456

     

     

     

    —

     

    Adjusted Gross Profit

    $

    120,244

     

     

    $

    105,148

     

     

    $

    362,874

     

     

    $

    324,518

     

     

     

     

     

     

     

     

     

    Selling, general, and administrative expenses

    $

    116,375

     

     

    $

    111,480

     

     

    $

    358,020

     

     

    $

    344,404

     

    Adjusted to exclude the following:

     

     

     

     

     

     

     

    Stock-based compensation expense(1)

     

    7,029

     

     

     

    10,680

     

     

     

    28,608

     

     

     

    38,563

     

    Non-cash charitable donation(3)

     

    —

     

     

     

    —

     

     

     

    2,821

     

     

     

    2,196

     

    System implementation costs(4)

     

    827

     

     

     

    —

     

     

     

    1,173

     

     

     

    —

     

    Other costs(5)

     

    560

     

     

     

    176

     

     

     

    2,428

     

     

     

    1,479

     

    Adjusted Selling, General, and Administrative Expenses

    $

    107,959

     

     

    $

    100,624

     

     

    $

    322,990

     

     

    $

    302,166

     

     

     

     

     

     

     

     

     

    Net cash provided by operating activities

    $

    17,974

     

     

    $

    27,282

     

     

    $

    87,531

     

     

    $

    78,832

     

    Purchases of property and equipment

     

    (19,490

    )

     

     

    (14,223

    )

     

     

    (51,928

    )

     

     

    (46,311

    )

    Free Cash Flow

    $

    (1,516

    )

     

    $

    13,059

     

     

    $

    35,603

     

     

    $

    32,521

     

    (1)

    Represents expenses related to the Company's equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions. For the three months ended September 30, 2025 and 2024, the amount includes $0.3 million and $0.2 million, respectively, of employer payroll taxes associated with releases of RSUs and option exercises. For the nine months ended September 30, 2025 and 2024, the amount includes $1.2 million and $0.7 million, respectively, of employer payroll taxes associated with releases of RSUs and option exercises.

    (2)

    Represents one-time inventory write-downs primarily related to the decision to sunset our Home-Try On program at the end of this year.

    (3)

    Represents charitable expense recorded in connection with the donation of 178,572 shares of Class A common stock in both May 2025 and May 2024 to the Warby Parker Impact Foundation.

    (4)

    Represents costs related to the implementation of major new enterprise software systems.

    (5)

    Represents restructuring costs incurred in the second quarter of 2025 and charges for certain legal matters outside the ordinary course of business.

    Source: Warby Parker Inc.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251106795106/en/

    Investor Relations:

    Jaclyn Berkley, Head of Investor Relations

    Brendon Frey, ICR

    [email protected]

    Media:

    Lena Griffin

    [email protected]

    Get the next $WRBY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WRBY

    DatePrice TargetRatingAnalyst
    11/7/2025$28.00 → $24.00Outperform
    Telsey Advisory Group
    8/1/2025$22.00 → $28.00Outperform
    Telsey Advisory Group
    7/10/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    4/30/2025$17.00Sell → Neutral
    Citigroup
    4/17/2025$27.00Hold → Buy
    Loop Capital
    2/28/2025$28.00 → $30.00Outperform
    Telsey Advisory Group
    2/25/2025$26.00Neutral
    ROTH MKM
    2/5/2025$19.00 → $23.00Neutral → Sell
    Citigroup
    More analyst ratings

    $WRBY
    SEC Filings

    View All

    SEC Form 10-Q filed by Warby Parker Inc.

    10-Q - Warby Parker Inc. (0001504776) (Filer)

    11/6/25 5:03:39 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Warby Parker Inc. (0001504776) (Filer)

    11/6/25 6:46:27 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Warby Parker Inc.

    SCHEDULE 13G/A - Warby Parker Inc. (0001504776) (Subject)

    11/5/25 11:49:28 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Warby Parker Announces Third Quarter 2025 Results

    Net revenue growth accelerated to 15% year over year Active Customers growth accelerated to 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the third quarter ended September 30, 2025. "This was a strong quarter for our team as we advanced our strategic priorities and accelerated both topline and customer growth. As we step into Warby Parker's next act, one defined by innovation through AI, we're energized to create new products like AI glasses, enhance the customer experience and drive productivity," shared Co-Founder and Co-CEO Neil Blume

    11/6/25 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker to Announce Third Quarter 2025 Financial Results November 6, 2025

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2025 will be released before market open on November 6, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 646-844-6383 from international locations. The conference passcode is 958403. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where p

    10/16/25 7:00:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Monumental Sports & Entertainment Appoints Corporate Finance Executive Steven Miller as Executive Vice President and Chief Financial Officer

    Steven Miller, currently Chief Financial Officer and Treasurer of Warby Parker (NYSE: WRBY), has been appointed Chief Financial Officer of Monumental Sports & Entertainment, effective October 2, 2025, and will join the Senior Executive Leadership TeamAs previously announced, after an extraordinary 25-year career at Monumental Sports & Entertainment, Peter Biché transitioned from Chief Financial Officer to Senior Advisor WASHINGTON, Sept. 9, 2025 /PRNewswire/ -- Monumental Sports & Entertainment (MSE), one of the nation's leading integrated sports, media, and entertainment companies, announced that Steven (Steve) Miller will become its Executive Vice President and Chief Financial Officer (CFO

    9/9/25 6:30:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

    Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $24.00 from $28.00 previously

    11/7/25 7:48:31 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

    Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $28.00 from $22.00 previously

    8/1/25 8:16:04 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker downgraded by Citizens JMP

    Citizens JMP downgraded Warby Parker from Mkt Outperform to Mkt Perform

    7/10/25 8:37:20 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Gilboa David Abraham converted options into 125,000 shares and sold $3,412,500 worth of shares (125,000 units at $27.30) (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    10/3/25 5:50:14 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Co-Chief Executive Officer Gilboa David Abraham sold $1,626,081 worth of shares (58,960 units at $27.58) and converted options into 58,960 shares (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    9/19/25 5:42:06 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Co-Chief Executive Officer Blumenthal Neil Harris converted options into 8,916 shares and sold $245,368 worth of shares (8,916 units at $27.52) (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    9/19/25 5:40:24 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Singer Bradley E bought $965,750 worth of shares (75,000 units at $12.88) (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    8/14/24 4:52:02 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Leadership Updates

    Live Leadership Updates

    View All

    Monumental Sports & Entertainment Appoints Corporate Finance Executive Steven Miller as Executive Vice President and Chief Financial Officer

    Steven Miller, currently Chief Financial Officer and Treasurer of Warby Parker (NYSE: WRBY), has been appointed Chief Financial Officer of Monumental Sports & Entertainment, effective October 2, 2025, and will join the Senior Executive Leadership TeamAs previously announced, after an extraordinary 25-year career at Monumental Sports & Entertainment, Peter Biché transitioned from Chief Financial Officer to Senior Advisor WASHINGTON, Sept. 9, 2025 /PRNewswire/ -- Monumental Sports & Entertainment (MSE), one of the nation's leading integrated sports, media, and entertainment companies, announced that Steven (Steve) Miller will become its Executive Vice President and Chief Financial Officer (CFO

    9/9/25 6:30:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker appoints Ronald A. Williams as Lead Director and welcomes Bradley E. Singer to Board of Directors

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company") announced today the appointment of Ron Williams as Lead Director. "Ron's deep expertise in transformational leadership is helping Warby Parker lead the way in making the optical industry more customer and patient friendly. Our shareholders and our team are lucky to have such an exceptional and experienced leader as our first Lead Director," said Neil Blumenthal, co-Founder and co-CEO. The Company has also appointed a new independent director, Brad Singer, to its board of directors. Mr. Singer's appointment is effective today, August 1, 2024. "Brad brings a wealth of experience as a dynamic operator and investor," said Dav

    8/1/24 4:15:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Financials

    Live finance-specific insights

    View All

    Warby Parker Announces Third Quarter 2025 Results

    Net revenue growth accelerated to 15% year over year Active Customers growth accelerated to 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the third quarter ended September 30, 2025. "This was a strong quarter for our team as we advanced our strategic priorities and accelerated both topline and customer growth. As we step into Warby Parker's next act, one defined by innovation through AI, we're energized to create new products like AI glasses, enhance the customer experience and drive productivity," shared Co-Founder and Co-CEO Neil Blume

    11/6/25 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker to Announce Third Quarter 2025 Financial Results November 6, 2025

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2025 will be released before market open on November 6, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 646-844-6383 from international locations. The conference passcode is 958403. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where p

    10/16/25 7:00:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Announces Second Quarter 2025 Results

    Net revenue increased 14% year over year to $214 million; Raises outlook Active Customers increased 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the second quarter ended June 30, 2025. "It has been a busy and exciting year marked by major milestones. We celebrated opening our 300th store and distributing 20 million pairs of glasses to people in need around the world. Looking ahead, our partnership with Google to develop intelligent eyewear is a testament to Warby Parker's commitment to innovation as we shape the future of how people

    8/7/25 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    11/14/24 5:08:23 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    11/14/24 1:30:16 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    11/12/24 10:40:28 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care